After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
Seat sharing has been announced in Mahavikas Aghadi. In Maharashtra, Shiv Sena (Uddhav faction) w
In the last 24 hours, 11,738 new cases of corona have been found in the country, while 29 people
On Tuesday, 16 people were injured in a shooting at a subway station in New York, USA, while thre
After almost 22 months, PML-N leader Shehbaz Sharif has once again taken oath as the Prime Minist
The Union Health Ministry has given important information on the condition of corona in the count
We had come to see our stars. We had bought tickets for the ceremony but could not enter the stad
These Smartphones are available with tremendous cameras, know the price and features
New Delhi: If you are fond of photography, then there are many such smartphones available in the
Bollywood actor Shahid Kapoor's much-loved film Jersey has been released in theaters this Friday.
The third match of the three-match T20 series was played between India and South Africa in Johann
The US supports temporary abolition of patent on corona vaccine, know what it means
The war against the Coronavirus has raised great hope for poor and middle-income countries. The U
